MedPath

A Retrospective Study to Collect the Data From the Patients Who Had the Perimount Heart Valve Replacement Surgery in China During 2001 to 2007

Completed
Conditions
Mitral Valve or Aortic Valve Replacement
Registration Number
NCT02381678
Lead Sponsor
Edwards (Shanghai) Lifesciences Medical Supplies Co., Ltd.
Brief Summary

The objective of the study is to obtain the clinical data from patients who had the Perimount Heat Valve (Type:6900P and 2900) Replacement Surgery in Guangdong General Hospital during 2001-2007 in order to evaluate the performace of this heart valve prothesis and collect the patients' post-operation infomation including the current living status, mortality rate, and the possibility of re-operation,bleeding and thrombosis.

This is a retrospective , observentional clinical study to be conducted in Guangdong General Hospital in China. This study will enroll up to 200 patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
225
Inclusion Criteria
  • The patients who implanted with Perimount Heart Valve (Type: 6900P and 2900) during 2001-2007 in Guangdong General Hospital in China
  • The patients agree to join the study and sign the ICF
Exclusion Criteria
  • No specific exclusion criteria

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The Performance Evaluation of Perimount Heart Valve(Type:6900P and 2900) by Echocardiography7-15 years after heart valve replacement surgery (during 2001-2007)

This is a one-arm study. All enrolled 225 subjects are required to be back Gungdong General Hospital to do an Echocardiography

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Guangdong General Hospital

🇨🇳

Guangzhou, Guangdong, China

Guangdong General Hospital
🇨🇳Guangzhou, Guangdong, China

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.